Repairing the brain in Parkinson's disease: Where next?BARKER, Roger A.Movement disorders. 2002, Vol 17, Num 2, pp 233-241, issn 0885-3185Article

The future challenges in Parkinson's diseaseBARKER, Roger A; FOLTYNIE, Thomas.Journal of neurology. 2004, Vol 251, Num 3, pp 361-365, issn 0340-5354, 5 p.Article

Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's diseaseSTOTT, Simon R. W; BARKER, Roger A.European journal of neuroscience (Print). 2014, Vol 39, Num 5-6, pp 1042-1056, issn 0953-816X, 15 p.Article

Graft-Induced Dyskinesias in Parkinson's Disease: What Is It All About?BARKER, Roger A; KUAN, Wei-Li.Cell stem cell. 2010, Vol 7, Num 2, pp 148-149, issn 1934-5909, 2 p.Article

The Current Clinical Management of Huntington's DiseasePHILLIPS, Wendy; SHANNON, Kathleen M; BARKER, Roger A et al.Movement disorders. 2008, Vol 23, Num 11, pp 1491-1504, issn 0885-3185, 14 p.Article

Neural transplantation therapies for Parkinson's and Huntington's diseasesBARKER, Roger A; ROSSER, Anne E.Drug discovery today. 2001, Vol 6, Num 11, pp 575-582, issn 1359-6446Article

The heterogeneity of idiopathic Parkinson's diseaseFOLTYNIE, Thomas; BRAYNE, Carol; BARKER, Roger A et al.Journal of neurology. 2002, Vol 249, Num 2, pp 138-145, issn 0340-5354Article

SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: A case reportWILKINS, Alastair; BROWN, Jerry M; BARKER, Roger A et al.Movement disorders. 2004, Vol 19, Num 5, pp 593-595, issn 0885-3185, 3 p.Article

Dopamine stimulates epidermal growth factor release from adult neural precursor cells derived from the subventricular zone by a disintegrin and metalloproteaseO'KEEFFE, Gráinne C; BARKER, Roger A.Neuroreport (Oxford). 2011, Vol 22, Num 18, pp 956-958, issn 0959-4965, 3 p.Article

Parkinson's disease and 2009: recent advancesBREEN, David P; BARKER, Roger A.Journal of neurology. 2010, Vol 257, Num 7, pp 1224-1228, issn 0340-5354, 5 p.Article

How vital is sleep in Huntington's disease?GOODMAN, Anna O. G; BARKER, Roger A.Journal of neurology. 2010, Vol 257, Num 6, pp 882-897, issn 0340-5354, 16 p.Article

Limbic neurogenesis/plasticity in the R6/2 mouse model of Huntington's diseasePHILLIPS, Wendy; MORTON, A. Jennifer; BARKER, Roger A et al.Neuroreport (Oxford). 2006, Vol 17, Num 15, pp 1623-1627, issn 0959-4965, 5 p.Article

Neurodegeneration: a failure of neuroregeneration?ARMSTRONG, Richard J. E; BARKER, Roger A.Lancet (British edition). 2001, Vol 358, Num 9288, pp 1174-1176, issn 0140-6736Article

Parkinson's disease ― the continuing search for biomarkers : BIOMARKERS OF NEURODEGENERATIVE DISEASESBREEN, David P; MICHELL, Andrew W; BARKER, Roger A et al.Clinical chemistry and laboratory medicine. 2011, Vol 49, Num 3, pp 393-401, issn 1434-6621, 9 p.Article

The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopramKUAN, Wei-Li; ZHAO, Jing-Wei; BARKER, Roger A et al.Psychopharmacologia. 2008, Vol 197, Num 2, pp 279-293, issn 0033-3158, 15 p.Article

Revisiting the effects of Parkinson's disease and frontal lobe lesions on task switching: The role of rule reconfigurationKEHAGIA, Angie A; BARKER, Roger A; ROBBINS, Trevor W et al.Journal of neuropsychology (Print). 2014, Vol 8, Num 1, pp 53-74, issn 1748-6645, 22 p.Article

Intracellular SERS Nanoprobes For Distinction Of Different Neuronal Cell TypesHUEFNER, Anna; KUAN, Wei-Li; BARKER, Roger A et al.Nano letters (Print). 2013, Vol 13, Num 6, pp 2463-2470, issn 1530-6984, 8 p.Article

Role of brain imaging in early parkinsonismBREEN, David P; ROWE, James B; BARKER, Roger A et al.BMJ (Overseas and retired doctors ed.). 2011, Vol 342, Num 7795, pp 495-498, issn 1759-2151, 4 p.Article

Huntington's disease patients have selective problems with insightHO, Aileen K; ROBBINS, Anna O. G; BARKER, Roger A et al.Movement disorders. 2006, Vol 21, Num 3, pp 385-389, issn 0885-3185, 5 p.Article

Skin and platelet α-synuclein as peripheral biomarkers of Parkinson's diseaseMICHELL, Andrew W; LUHESHI, Leila M; BARKER, Roger A et al.Neuroscience letters. 2005, Vol 381, Num 3, pp 294-298, issn 0304-3940, 5 p.Article

The challenges of administering cell-based therapies to patients with Parkinson's diseaseDROUIN-OUELLET, Janelle; BARKER, Roger A.Neuroreport (Oxford). 2013, Vol 24, Num 18, pp 1000-1004, issn 0959-4965, 5 p.Conference Paper

The use of the Actiwatch-Neurologica® system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's diseaseHURELBRINK, Carrie B; LEWIS, Simon J. G; BARKER, Roger A et al.Journal of neurology. 2005, Vol 252, Num 6, pp 642-647, issn 0340-5354, 6 p.Article

Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD StudyYARNALL, Alison J; BREEN, David P; MOLLENHAUER, Brit et al.Neurology. 2014, Vol 82, Num 4, pp 308-316, issn 0028-3878, 9 p.Article

The spectrum of nonmotor symptoms in early Parkinson diseaseKHOO, Tien K; YARNALL, Alison J; DUNCAN, Gordon W et al.Neurology. 2013, Vol 80, Num 3, pp 276-281, issn 0028-3878, 6 p.Article

Genetic and Pathological Links Between Parkinson's Disease and the Lysosomal Disorder Sanfilippo SyndromeWINDER-RHODES, Sophie E; GARCIA-REITBÖCK, Pablo; BURN, David J et al.Movement disorders. 2012, Vol 27, Num 2, pp 312-315, issn 0885-3185, 4 p.Article